Overview
- Exports reached $30.47 billion in FY24-25, rising about 10% year on year, according to Commerce Secretary Rajesh Agrawal.
- More than 60% of shipments go to stringent-regulation destinations, with the United States at roughly 34% and Europe near 19%.
- At a Chintan Shivir in Chandigarh, officials emphasized tackling non-tariff barriers, expanding regulatory cooperation and pursuing mutual recognition to speed approvals.
- India’s domestic pharmaceutical market is estimated near $60 billion, with projections of roughly $130 billion by 2030.
- Wockhardt’s recent USFDA acceptance for an NDA for its Zaynich antibiotic was highlighted as a sign of rising innovation-led growth.